BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7512669)

  • 1. [Mutational analysis of platelet fibrinogen receptor ligand binding domain].
    Shimomura T; Fujimura K
    Rinsho Ketsueki; 1994 Mar; 35(3):224-9. PubMed ID: 7512669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells.
    Kieffer N; Fitzgerald LA; Wolf D; Cheresh DA; Phillips DR
    J Cell Biol; 1991 Apr; 113(2):451-61. PubMed ID: 1707057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity modulation of the alpha IIb beta 3 integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor.
    O'Toole TE; Loftus JC; Du XP; Glass AA; Ruggeri ZM; Shattil SJ; Plow EF; Ginsberg MH
    Cell Regul; 1990 Nov; 1(12):883-93. PubMed ID: 2100193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex.
    Calvete JJ
    Thromb Haemost; 1994 Jul; 72(1):1-15. PubMed ID: 7974356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of soluble fibrinogen binding to platelets by fluorescence-activated flow cytometry.
    Faraday N; Goldschmidt-Clermont P; Dise K; Bray PF
    J Lab Clin Med; 1994 May; 123(5):728-40. PubMed ID: 7515093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIA and alpha v beta 3 integrins in platelet protein trafficking.
    Coller BS; Seligsohn U; West SM; Scudder LE; Norton KJ
    Blood; 1991 Nov; 78(10):2603-10. PubMed ID: 1726706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic regulation of integrins.
    Faull RJ; Ginsberg MH
    Stem Cells; 1995 Jan; 13(1):38-46. PubMed ID: 7719247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A naturally occurring point mutation in the beta3 integrin MIDAS-like domain affects differently alphavbeta3 and alphaIIIbbeta3 receptor function.
    Morel-Kopp MC; Melchior C; Chen P; Ammerlaan W; Lecompte T; Kaplan C; Kieffer N
    Thromb Haemost; 2001 Dec; 86(6):1425-34. PubMed ID: 11776310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mutations in the cytoplasmic domain of integrin beta(1) to talin binding and cell spreading.
    Kääpä A; Peter K; Ylänne J
    Exp Cell Res; 1999 Aug; 250(2):524-34. PubMed ID: 10413605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for two functionally different fibrinogen receptors on hemopoietic cells: the glycoprotein IIb-IIIa and the mitogenic fibrinogen receptor.
    Levesque JP; Hatzfeld A; Hudry-Clergeon G; Wilner GD; Hatzfeld J
    J Cell Physiol; 1987 Aug; 132(2):303-10. PubMed ID: 3624317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligands "activate" integrin alpha IIb beta 3 (platelet GPIIb-IIIa).
    Du XP; Plow EF; Frelinger AL; O'Toole TE; Loftus JC; Ginsberg MH
    Cell; 1991 May; 65(3):409-16. PubMed ID: 2018974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A spontaneous mutation of integrin alpha IIb beta 3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site.
    Bajt ML; Ginsberg MH; Frelinger AL; Berndt MC; Loftus JC
    J Biol Chem; 1992 Feb; 267(6):3789-94. PubMed ID: 1371279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missense mutations in the beta(3) subunit have a different impact on the expression and function between alpha(IIb)beta(3) and alpha(v)beta(3).
    Tadokoro S; Tomiyama Y; Honda S; Kashiwagi H; Kosugi S; Shiraga M; Kiyoi T; Kurata Y; Matsuzawa Y
    Blood; 2002 Feb; 99(3):931-8. PubMed ID: 11806996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of the interaction of platelet membrane glycoprotein GPIIb-IIIa (alpha IIb beta 3) and its ligands.
    Plow EF; D'Souza SE; Ginsberg MH
    J Lab Clin Med; 1992 Aug; 120(2):198-204. PubMed ID: 1500819
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of cation-binding sequences in the platelet integrin GPIIb-IIIa (alpha IIb beta 3) by terbium luminescence.
    Cierniewski CS; Haas TA; Smith JW; Plow EF
    Biochemistry; 1994 Oct; 33(40):12238-46. PubMed ID: 7522557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mechanism for divalent cation regulation of beta 3-integrins.
    Smith JW; Piotrowicz RS; Mathis D
    J Biol Chem; 1994 Jan; 269(2):960-7. PubMed ID: 7507113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrafibricin has a high selectivity for GPIIb/IIIa: comparison of the effects of tetrafibricin and RGDS on GPIIb/IIIa and the vitronectin receptor.
    Satoh T; Kouns WC; Yamashita Y; Kamiyama T; Steiner B
    Biochem Biophys Res Commun; 1994 Oct; 204(1):325-32. PubMed ID: 7524499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a gain of function mutation of integrin alpha IIb beta 3 (platelet glycoprotein IIb-IIIa).
    Bajt ML; Loftus JC; Gawaz MP; Ginsberg MH
    J Biol Chem; 1992 Nov; 267(31):22211-6. PubMed ID: 1429573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An enzyme-linked immunosorbent assay to identify inhibitors of activation of platelet integrin alpha IIb beta 3.
    Gao J; Shattil SJ
    J Immunol Methods; 1995 Apr; 181(1):55-64. PubMed ID: 7537313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.